The coronavirus pandemic threw the entire world into a lurch and showed us just how difficult it can be to deal with a pandemic in our increasingly connected world. A few months after the virus was first discovered in Wuhan, China, dozens of countries shut down their borders to stop the disease from spreading at the cost of economic activity.
The coronavirus vaccine appears to have been instrumental in stopping COVID-19 infections, reducing negative health outcomes and opening up the world to international activity once again. However, although we are now through the worst of the pandemic, infections are still common and plenty of people currently deal with the symptoms of long COVID.
In fact, there have been several anecdotal reports of some people developing tinnitus after being vaccinated against the communicable disease. Tinnitus is a condition that causes patients to hear a high-pitched ringing sound or other sounds in one or both of their ears. It occurs with much more frequency in older people and affects around 15% to 20% of the population.
These anecdotal reports point to one of the COVID-19 vaccines as a possible cause for developing tinnitus. These reports may have some validity because other types of vaccines, such as the flu shot, are also thought to contribute to tinnitus by triggering an inflammatory response in patients. However, the Centers for Disease Control and Prevention (CDC) states that there is currently no evidence tying coronavirus vaccines to the development of tinnitus.
The University of California’s director of otology, neurology and skull base surgery Dr. Hamid. R Djalilian explains that it is currently unclear whether the COVID-19 vaccine triggers an inflammatory response in the body or whether there was simply an overlap between people with tinnitus and people who received the coronavirus vaccine.
Although research on the link between the COVID-19 vaccines and tinnitus is still scant, the amount of anecdotal reports on the connection warrant further research into the matter. A March 2022 report revealed that up to 12,247 people had reported developing tinnitus after receiving a COVID-19 vaccine. A different study from the same year listed tinnitus as one of the most common otolaryngology side effects in patients who received the COVID-19 vaccination.
A more recent paper from March 2023 stated that although the occurrence of tinnitus after COVID-19 vaccination is indeed rare, there are some cases where patients can develop severe tinnitus after vaccination. Yale Medicine infectious disease specialist Dr. Scott Roberts says that the CDC is currently investigating these reports to determine if there is an association between tinnitus and COVID-19 vaccines.
For those found to have developed tinnitus as a result of receiving the COVID jab, possible remedies from Jupiter Wellness Inc. (NASDAQ: JUPW) and other biotech companies are available to help in addressing the condition.
NOTE TO INVESTORS: The latest news and updates relating to Jupiter Wellness Inc. (NASDAQ: JUPW) are available in the company’s newsroom at https://ibn.fm/JUPW
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
